TyraTech Inc. (AIM: TYR or TYRU), a natural life sciences company, announces that at the Annual General Meeting of the Company held today, all resolutions were passed.
For further information please contact:
TyraTech Inc. Bruno Jactel, Chief Executive Officer Brian Phillips, Company Secretary |
Tel: +1 919 415 4340 Tel: +1 919 415 4304 |
N+1 Singer, Nominated Adviser and Joint Broker Jonny Franklin-Adams / Alex Wright |
Tel: +44 20 7496 3000 |
First Columbus LLP, Joint Broker Chris Crawford |
Tel: +44 20 3002 2070 |
Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.